Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts

A comparison of normalization methods for high densityoligonucleotide array data based on variance and bias

Benjamin M. Bolstad, Rafael A. Irizarry, Magnus Åstrand et al. · Bioinformatics · 2003 · 8.4K citations · Full text

Life Sciences, Bioinformatics, Biostatistics +10

Integrated genomic analyses of ovarian carcinoma

Debra Bell, Andrew Berchuck, Narciso Olvera et al. · Nature · 2011 · 8.2K citations · Full text

Medicine, Genetics, Oncology +14

REporting recommendations for tumour MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · British Journal of Cancer · 2005 · 1.4K citations · Full text

Medicine, Biostatistics, Oncology +10

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

Jaime Prat · International Journal of Gynecology & Obstetrics · 2013 · 1.3K citations · Full text

Medicine, Gynecology, Oncology +12

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)

Evan M. Kroh, Rachael K. Parkin, Patrick S. Mitchell et al. · Methods · 2010 · 1.2K citations

Medicine, Molecular Biology, Molecular Medicine +12